Published in J Thorac Cardiovasc Surg on August 11, 2011
HeartWare and HeartMate II left ventricular assist devices as bridge to transplantation: a comparative analysis. Ann Thorac Surg (2013) 1.41
Donor predictors of allograft use and recipient outcomes after heart transplantation. Circ Heart Fail (2013) 1.25
Risk factors for early death in patients bridged to transplant with continuous-flow left ventricular assist devices. Ann Thorac Surg (2012) 0.89
Influence of durable mechanical circulatory support and allosensitization on mortality after heart transplantation. J Heart Lung Transplant (2016) 0.75
Ventricular assist device use in congenital heart disease with a comparison to heart transplant. J Comp Eff Res (2014) 0.75
Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation. J Heart Lung Transplant (2017) 0.75
Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med (2007) 7.15
Creation of a quantitative recipient risk index for mortality prediction after cardiac transplantation (IMPACT). Ann Thorac Surg (2011) 2.10
Increased mortality at low-volume orthotopic heart transplantation centers: should current standards change? Ann Thorac Surg (2008) 1.68
Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg (2007) 1.39
Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization. J Heart Lung Transplant (2009) 1.37
Association of device surface and biomaterials with immunologic sensitization after mechanical support. J Thorac Cardiovasc Surg (2008) 1.16
Factors influencing HLA sensitization in implantable LVAD recipients. Ann Thorac Surg (1997) 1.06
Pediatric cardiac transplantation in children with high panel reactive antibody. Ann Thorac Surg (2004) 1.05
Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. J Heart Lung Transplant (1992) 1.02
Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes. J Heart Lung Transplant (2005) 0.99
The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation. Transpl Immunol (1993) 0.97
Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J Heart Lung Transplant (1992) 0.93
Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival. J Heart Lung Transplant (2001) 0.93
Utility of virtual crossmatch in sensitized patients awaiting heart transplantation. J Heart Lung Transplant (2009) 0.93
The impact of race on survival after heart transplantation: an analysis of more than 20,000 patients. Ann Thorac Surg (2010) 0.92
HLA sensitization in ventricular assist device recipients: does type of device make a difference? J Thorac Cardiovasc Surg (2004) 0.90
The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation. J Thorac Cardiovasc Surg (2010) 0.88
Detection of anti-HLA antibody by flow cytometry in patients with a left ventricular assist device is associated with early rejection following heart transplantation. Transplantation (2000) 0.88
The impact of race and HLA matching on long-term survival following cardiac transplantation. Transplant Proc (1997) 0.86
Bridge to transplant experience: factors influencing survival to and after cardiac transplant. J Thorac Cardiovasc Surg (2010) 0.86
Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization. J Heart Lung Transplant (1999) 0.86
Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med (2009) 12.77
Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet (2012) 9.86
Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med (2007) 7.15
International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant (2006) 4.95
Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol (2009) 4.03
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant (2010) 4.00
Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol (2010) 3.63
Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med (2013) 3.38
Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol (2011) 3.06
Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation (2006) 3.01
Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation (2005) 2.94
Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med (2003) 2.80
The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant (2013) 2.71
Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation (2006) 2.69
Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol (2007) 2.53
Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg (2007) 2.48
Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study. J Am Coll Cardiol (2009) 2.44
Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg (2004) 2.41
Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg (2010) 2.29
Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J (2009) 2.29
Lung injury and acute respiratory distress syndrome after cardiac surgery. Ann Thorac Surg (2013) 2.29
Clinical outcomes of noninfectious sternal dehiscence after median sternotomy. Ann Thorac Surg (2006) 2.25
Electrocardiographic features of arrhythmogenic right ventricular dysplasia. Circulation (2009) 2.22
Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Cardiovasc Genet (2009) 2.19
Transcriptomic biomarkers for individual risk assessment in new-onset heart failure. Circulation (2008) 2.15
Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation (2002) 2.14
Should orthotopic heart transplantation using marginal donors be limited to higher volume centers? Ann Thorac Surg (2012) 2.13
Creation of a quantitative recipient risk index for mortality prediction after cardiac transplantation (IMPACT). Ann Thorac Surg (2011) 2.10
Effect of increasing pump speed during exercise on peak oxygen uptake in heart failure patients supported with a continuous-flow left ventricular assist device. A double-blind randomized study. Eur J Heart Fail (2014) 1.99
Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members. Circ Cardiovasc Genet (2015) 1.94
Coronary artery bypass grafting with or without surgical ventricular restoration: a comparison. Ann Thorac Surg (2008) 1.92
Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation (2011) 1.92
DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Hum Genet (2006) 1.85
BIN1 is reduced and Cav1.2 trafficking is impaired in human failing cardiomyocytes. Heart Rhythm (2011) 1.85
Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation (2009) 1.84
The STICH trial unravelled. Eur J Heart Fail (2010) 1.82
Surgical repair of ventricular septal defect after myocardial infarction: outcomes from the Society of Thoracic Surgeons National Database. Ann Thorac Surg (2012) 1.80
Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing). Am J Cardiol (2008) 1.79
PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail (2008) 1.75
The gene expression profile of patients with new-onset heart failure reveals important gender-specific differences. Eur Heart J (2009) 1.73
Increased mortality at low-volume orthotopic heart transplantation centers: should current standards change? Ann Thorac Surg (2008) 1.68
Impact of the lung allocation score on resource utilization after lung transplantation in the United States. J Heart Lung Transplant (2010) 1.67
Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol (2013) 1.66
Salvage chemotherapy regimens for acute myeloid leukemia: Is one better? Efficacy comparison between CLAG and MEC regimens. Leuk Res (2010) 1.63
Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J (2006) 1.62
Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant (2009) 1.62
Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery. J Am Coll Cardiol (2011) 1.59
Impact of U.S. Lung Allocation Score on survival after lung transplantation. J Heart Lung Transplant (2009) 1.58
Simple score to assess the risk of rejection after orthotopic heart transplantation. Circulation (2012) 1.57
The effect of volume on esophageal cancer resections: what constitutes acceptable resection volumes for centers of excellence? J Thorac Cardiovasc Surg (2009) 1.55
Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol Genomics (2005) 1.54
Lung size mismatch and survival after single and bilateral lung transplantation. Ann Thorac Surg (2013) 1.54
Lung transplant in idiopathic pulmonary fibrosis. Arch Surg (2011) 1.53
Cerebral Autoregulation Monitoring with Ultrasound-Tagged Near-Infrared Spectroscopy in Cardiac Surgery Patients. Anesth Analg (2015) 1.52
Past history of skin infection and risk of surgical site infection after elective surgery. Ann Surg (2013) 1.52
Identifying recipients at high risk for graft failure after heart retransplantation. Ann Thorac Surg (2012) 1.51
Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices? Ann Thorac Surg (2012) 1.50
Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study. Circ Heart Fail (2012) 1.50
Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy. Circulation (2004) 1.47
Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol (2006) 1.46
Aortic valve replacement and concomitant coronary artery bypass: assessing the impact of multiple grafts. Ann Thorac Surg (2007) 1.46
Length of red cell unit storage and risk for delirium after cardiac surgery. Anesth Analg (2014) 1.46
Left ventricular assist device driveline infections. Cardiol Clin (2011) 1.45
Orthotopic heart transplantation in patients with metabolic risk factors. Ann Thorac Surg (2012) 1.44
Surgical ventricular restoration versus cardiac transplantation: a comparison of cost, outcomes, and survival. J Card Fail (2008) 1.43
Lung transplantation in older patients with cystic fibrosis: analysis of UNOS data. J Heart Lung Transplant (2009) 1.43
Hemoglobin drift after cardiac surgery. Ann Thorac Surg (2012) 1.42